Real World Evidence
Biomarkers are now a routine part of drug development. BBCR can help you understand their role and move your product to market faster.
October 7th, 2019 | Real World EvidenceDo Not Make Mistakes!
September 30th, 2019 | Real World Evidence
Microbiome and ALS: An Unsuspected Link
September 26th, 2019 | Real World Evidence
The FDA Innovation Office
September 19th, 2019 | Real World Evidence
Links between the Microbiome and Autoimmunity are nothing new
September 12th, 2019 | Real World Evidence
Alzheimer’s Disease and Periodontal Disease Linked by Anaerobic Bacteria
September 3rd, 2019 | Real World Evidence
Inventor of the PCR, Kary Mullis, Dies
August 15th, 2019 | Real World Evidence
Longer Stretch To The Finish Line for CNS Diseases
August 7th, 2019 | Real World Evidence
Cost vs. Value: Can We Have Both?
August 1st, 2019 | Real World Evidence
Could Seamless Adaptive Designs Advance Rare Disease Clinical Trial Design?
July 24th, 2019 | Real World Evidence